Search results
Results from the WOW.Com Content Network
However, Chae said not everyone qualifies for weight loss medication and there are side effects to consider like gastrointestinal problems and gallbladder disease. "In the long term, the ...
Retatrutide (LY-3437943) is an experimental drug for obesity developed by American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist ( GLP-1 , GIP , and GCGR receptors). [ 1 ]
The most common side effects of these drugs that led to withdrawals were mental disturbances, cardiac side effects, and drug abuse or drug dependence. Deaths were associated with seven products. [84] Ephedra was removed from the US market in 2004 over concerns that it raises blood pressure and could lead to strokes and death. [85]
At 48 weeks, for example, retatrutide had reduced levels of triglycerides by up to 40.6%, and levels of a protein called apoC-III involved in glucose metabolism and inflammation by 38%.
Eli Lily’s weight-loss drug retatrutide helped patients lose 24% of their body weight, new data shows. The results rivaled Ozempic. Experts share what to know.
Common side effects include low blood sugar, nausea, dizziness, abdominal pain, and pain at the site of injection. [6] [10] Gastrointestinal side-effects tend to be strongest at the beginning of treatment period and subside over time. [10] Other serious side effects may include angioedema, pancreatitis, gallbladder disease, and kidney problems. [6]
A study confirmed that side effects like pancreatitis and kidney damage are possible while taking GLP-1s like Ozempic. Here's what a doctor wants you to know.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more